Szabolcs Modok
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Metal complexes synthesis and properties
-
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 9
- Drug Transport and Resistance Mechanisms 7
- Metal complexes synthesis and properties 4
-
- Sphingolipid Metabolism and Signaling 2
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 1
- Co-authors
- Richard Callaghan (11 shared papers)Howard R. Mellor (6 shared papers)Robert C. Ford (2 shared papers)Mark F. Rosenberg (1 shared paper)Christopher F. Higgins (1 shared paper)Trevor W. Hambley (4 shared papers)Catherine A. Heyward (1 shared paper)Rebecca A. Alderden (3 shared papers)
- Journals
- Biochemical Pharmacology (2 papers)Journal of Lipid Research (1 paper)British Journal of Cancer (1 paper)Journal of the American Chemical Society (1 paper)Current Opinion in Pharmacology (1 paper)
- Partner nations
- United KingdomAustraliaCanada
In The Last Decade
Szabolcs Modok
11 papers receiving 673 citations
Peers
Comparison fields: 5 of 82
- Oncology 458
- Biomaterials 66
- Pediatrics, Perinatology and Child Health 93
- Molecular Biology 323
- Infectious Diseases 82
Countries citing papers authored by Szabolcs Modok
This map shows the geographic impact of Szabolcs Modok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szabolcs Modok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szabolcs Modok more than expected).
Fields of papers citing papers by Szabolcs Modok
This network shows the impact of papers produced by Szabolcs Modok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szabolcs Modok. The network helps show where Szabolcs Modok may publish in the future.
Co-authors
The 25 scholars most cited alongside Szabolcs Modok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 200 | |
| 2 | 2004 | 126 | |
| 3 | 2006 | 96 | |
| 4 | 2004 | 60 | |
| 5 | 2007 | 52 | |
| 6 | 2006 | 42 | |
| 7 | 2005 | 40 | |
| 8 | 2007 | 28 | |
| 9 | 2006 | 20 | |
| 10 | 2008 | 15 | |
| 11 | 2006 | 4 |
About Szabolcs Modok
Szabolcs Modok is a scholar working on Oncology, Molecular Biology, Biomaterials, Nutrition and Dietetics and Infectious Diseases, having authored 11 papers that have together received 683 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Metal complexes synthesis and properties (4 papers), Trace Elements in Health (2 papers), Sphingolipid Metabolism and Signaling (2 papers), RNA Interference and Gene Delivery (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and Electron and X-Ray Spectroscopy Techniques (1 paper). The work is most often cited by research in Oncology (458 citations), Biomaterials (66 citations), Pediatrics, Perinatology and Child Health (93 citations), Molecular Biology (323 citations) and Infectious Diseases (82 citations). Szabolcs Modok has collaborated with scholars based in United Kingdom, Australia and Canada. Frequent co-authors include Richard Callaghan, Howard R. Mellor, Robert C. Ford, Mark F. Rosenberg, Christopher F. Higgins, Trevor W. Hambley, Catherine A. Heyward, Rebecca A. Alderden, Ian D. Kerr and Matthew D. Hall. Their work appears in journals such as Biochemical Pharmacology, Journal of Lipid Research, British Journal of Cancer, Journal of the American Chemical Society and Current Opinion in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.